Short description
Eyetech Pharmaceuticals is a biopharmaceutical company that specializes in novel therapeutics to treat diseases of the eye.
Description
Eyetech Pharmaceuticals is a biopharmaceutical company that specializes in novel therapeutics to treat diseases of the eye. The company conducted research and development into wet age-related macular degeneration diseases, which was seen as a breakthrough in the field.
Valeant Pharmaceuticals International acquired Eyetech for US$22 million in 2012.
Last funding
Noaccess
Sign in for full access
Total funding
$$3123123
Sign in for full access
Location
New York, New York, United States, North America
Founded on
January 1, 1997
Closed on
January 1, 2021
Exited on
January 30, 2004
Went public on
January 30, 2004
Delisted on
March 1, 2012
Stock symbol
EYET
Non-profit?
No
Acquired?
No
Employees count
251-500
Investors
Absolutely Noaccess, Noway Youcantaccess, Noway Youcantaccess, Noaccessforu, Nopepepe, Uh Ohhhh
Sign in for full access
Founders
Anthony P. Adamis, David Guyer, Marty Glick, Samir Patel